The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism

JAMA Surgery

Volumn 151, Issue 10, 2016, Pages 959-968

  Wilhelm, Scott M ^a   Wang, Tracy S ^b   Ruan, Daniel T ^c   Lee, James A ^d   Asa, Sylvia L ^e   Duh, Quan Yang ^f   Doherty, Gerard M ^g   Herrera, Miguel F ^h   Pasieka, Janice L ⁱ   Perrier, Nancy D ^j   Silverberg, Shonni J ^d   Solórzano, Carmen C ^k   Sturgeon, Cord ^l   Tublin, Mitchell E ^m   Udelsman, Robert ⁿ   Carty, Sally E ^o  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Columbia University College of Physicians ^*  (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BOSTON MEDICAL CENTER   (United States)

^h INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE;

ARTICLE; CALCIUM URINE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; EVIDENCE BASED MEDICINE; HEMATOMA; HUMAN; HYPOCALCEMIA; INTRAOPERATIVE PERIOD; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PARATHYROIDECTOMY; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REOPERATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; AUTOGRAFT; COMPLICATION; DIAGNOSTIC IMAGING; ENDOCRINOLOGY; HYPERPARATHYROIDISM; PARATHYROID GLAND; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES; STANDARDS; TRANSPLANTATION;

AUTOGRAFTS; ENDOCRINOLOGY; HUMANS; HYPERPARATHYROIDISM; PARATHYROID GLANDS; PARATHYROIDECTOMY; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SPECIALTIES, SURGICAL;

EID: 84997447933     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2016.2310     Document Type: Article

References (42)

1. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10): 3561-3569.
2. Marcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014;99(10):3607-3618.
3. Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10): 3570-3579.
4. Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10): 3580-3594.
5. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010;153(3):194-199.
6. Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism. Arq Bras Endocrinol Metabol. 2010;54(2):106-109.
7. Evans DB, Rich TA, Cote GJ. Surgical management of familial hyperparathyroidism. Ann Surg Oncol. 2007;14(5):1525-1527.
8. Stålberg P, Carling T. Familial parathyroid tumors: diagnosis and management. World J Surg. 2009;33(11):2234-2243.
9. Thakker RV, Newey PJ, Walls GV, et al; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990-3011.
10. Awad SS, Miskulin J, Thompson N. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg. 2003; 27(4):486-488.
11. Pasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery. 2009;146(6): 1006-1013.
12. Pasieka JL, Parsons LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg. 1998;22(6): 513-518.
13. Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg. 2002;137 (9):1022-1026.
14. Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92(8):3114-3121.
15. Zanocco K, Angelos P, Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery. 2006;140 (6):874-881.
16. Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003;327(7414):530-534.
17. Rolighed L, Amstrup AK, Jakobsen NF, et al. Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism. World J Surg. 2014;38(3):549-557.
18. Reiher AE, Mazeh H, Schaefer S, Gould J, Chen H, Sippel RS. Symptoms of gastroesophageal reflux disease improve after parathyroidectomy. Surgery. 2012;152(6):1232-1237.
19. Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002;325(7368):807.
20. Silverberg SJ, Brown I, Bilezikian JP. Age as a criterion for surgery in primary hyperparathyroidism. Am J Med. 2002;113(8): 681-684.
21. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab. 2004;89(11):5415-5422.
22. Abdulla AG, Ituarte PH, Harari A, Wu JX, Yeh MW. Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years. Ann Surg. 2015;261(4):746-750.
23. Zanocco K, Sturgeon C. How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? a cost-effectiveness analysis. Surgery. 2008;144(2): 290-298.
24. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93(9):3462-3470.
25. Rodgers SE, Hunter GJ, Hamberg LM, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006;140(6): 932-940.
26. Solorzano CC, Carneiro-Pla D. Minimizing cost and maximizing success in the preoperative localization strategy for primary hyperparathyroidism. Surg Clin North Am. 2014;94(3):587-605.
27. Lubitz CC, Hunter GJ, Hamberg LM, et al. Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery. 2010;148 (6):1129-1137.
28. Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA. Would scan, but which scan? a cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism. Surgery. 2011;150(6): 1286-1294.
29. Starker LF, Björklund P, Theoharis C, Long WD III, Carling T, Udelsman R. Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg. 2011;35(2):331-335.
30. Irvin GL III, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239(5):704-708.
31. McCoy KL, Chen NH, Armstrong MJ, et al. The small abnormal parathyroid gland is increasingly common and heralds operative complexity. World J Surg. 2014;38(6): 1274-1281.
32. Allendorf J, Di Gorgi M, Spanknebel K, Inabnet W, Chabot J, Logerfo P. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31(11): 2075-2080.
33. Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15(9): 1055-1059.
34. van Heerden JA, Weiland LH, Re Mine WH, Walls JT, Purnell DC. Cancer of the parathyroid glands. Arch Surg. 1979;114(4):475-480.
35. Udelsman R, Åkerström G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10): 3595-3606.
36. Stewart ZA, Blackford A, Somervell H, et al. 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery. 2005;138(6): 1018-1025.
37. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236(5):543-551.
38. Roman SA, Sosa JA, Pietrzak RH, et al. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011; 253(1):131-137.
39. Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004;70(2):114-119.
40. Stack BC Jr, Bimston DN, Bodenner DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: postoperative hypoparathyroidism-definitions and management. Endocr Pract. 2015;21(6):674-685.
41. Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK. Reoperations for primary hyperparathyroidism: improvement of outcome over two decades. Langenbecks Arch Surg. 2013;398(1):99-106.
42. Weber CJ, Sewell CW, McGarity WC. Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation. Surgery. 1994;116(6):991-998.